Professor David Barlow

Honorary Senior Research Fellow (School of Medicine, Dentistry & Nursing)

email: David.Barlow@glasgow.ac.uk

R207 Level 2, School of Medicine Admin, Wolfson Medical School Building, Glasgow G12 8QQ

Import to contacts

Publications

List by: Type | Date

Jump to: 2017 | 2014 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

Number of items: 72.

2017

Fauser, B. C.J.M. et al. (2017) Safety after extended repeated use of ulipristal acetate for uterine fibroids. PLoS ONE, 12(3), e0173523. (doi: 10.1371/journal.pone.0173523) (PMID:28267814) (PMCID:PMC5340384)

2014

Donnez, J. et al. (2014) Long-term treatment of uterine fibroids with ulipristal acetate. Fertility and Sterility, 101(6), 1565-1573.e18. (doi: 10.1016/j.fertnstert.2014.02.008)

Barlow, D.H., Lumsden, M.A. , Fauser, B.C.J.M., Terrill, P. and Bestel, E. (2014) Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo. Human Reproduction, 29(3), pp. 480-489. (doi: 10.1093/humrep/det467) (PMID:24457604)

2012

Williams, A., Bergeron, C., Barlow, D.H. and Ferenczy, A. (2012) Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. International Journal of Gynecological Pathology, 31(6), pp. 556-569. (doi: 10.1097/PGP.0b013e318251035b)

Van Poznak, C., Makris, A., Clack, G., Barlow, D.H. and Eastell, R. (2012) Lipid profiles within the SABRE trial of anastrozole with and without risedronate. Breast Cancer Research and Treatment, 134(3), pp. 1141-1147. (doi: 10.1007/s10549-012-2147-9)

2011

Barlow, D.H. (2011) Interventions in the prolongation of reproductive life in women. Annals of the New York Academy of Sciences, 1221, pp. 1-9. (doi: 10.1111/j.1749-6632.2011.05968.x)

2010

Van Poznak, C., Hannon, R.A., Mackey, J.R., Campone, M., Apffelstaedt, J.P., Clack, G., Barlow, D., Makris, A. and Eastell, R. (2010) Prevention of Aromatase Inhibitor-Induced Bone Loss Using Risedronate: The SABRE Trial. Journal of Clinical Oncology, 28(6), pp. 967-975. (doi: 10.1200/JCO.2009.24.5902)

2008

Barlow, D. (2008) The medical management of menopause - To treat or not to treat? Assessment of Human Reproductive Function, 1127, pp. 134-139.

Barlow, D. (2008) What is the optimal policy for osteoporosis management? Maturitas, 60(1), pp. 3-9.

Birkhauser, M., Panay, N., Archer, D., Barlow, D., Burger, H., Gambacciani, M., Pinkerton, J., Goldstein, S. and Sturdee, D. (2008) Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric, 11(2), pp. 108-123.

Gompel, A., Rozenberg, S. and Barlow, D. (2008) The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas, 61(3), pp. 227-232.

Van Staa, T.P., Cooper, C., Barlow, D.H. and Leufkens, H.G.M. (2008) Individualizing the risks and benefits of postmenopausal hormone therapy. Menopause: The Journal of the North American Menopause Society, 15(2), pp. 374-381.

2007

Barlow, D. (2007) Osteoporosis guidelines. Climacteric, 10, pp. 79-82. (doi: 10.1080/13697130701586113)

Gompel, A., Barlow, D., Rozenberg, S. and Skouby, S. (2007) The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy. Maturitas, 56(2), pp. 227-229.

Van Staa, T., Cooper, C., Barlow, D. and Leufkens, H. (2007) Individualising the risks and benefits of postmenopausal hormone therapy. Drug Safety, 30(10), p. 928.

2006

Barlow, D.H. (2006) What do we think about cognition and menopause? Menopause: The Journal of the North American Menopause Society, 13(1), pp. 4-5.

Barlow, D. (2006) Human Reproduction - the next phase in its development. Human Reproduction, 21(10), pp. 2463-2465.

Barlow, D. (2006) Taking stock and moving forward. Human Reproduction, 21(12), pp. 3033-3035.

Barlow, D., Ellis, J., Goldacre, M., Hey, K., Murphy, M., Neale, R., Seagroatt, V., Vessey, M. and Willis, B. (2006) Pregnancy outcome among twins conceived after subfertility treatment compared with natural twins: A population-based study. Twin Research and Human Genetics, 9(2), pp. 279-284.

Barlow, D., Marchington, D., Poulton, J. and Scott-Brown, M. (2006) Mosaicism for mitochondrial DNA polymorphic variants in placenta has implications for the feasibility of prenatal diagnosis in mtDNA diseases. European Journal of Human Genetics, 14(7), pp. 816-823.

Gompel, A., Barlow, D., Rozenberg, S. and Skouby, S. (2006) Updating the EMAS 2004/2005 clinical recommendations on postmenopausal therapy following the recent publications: WHI and Nurses' Health Study. Maturitas, 55(1), pp. 1-4.

Turner, G., Lambert, T., Goldacre, M. and Barlow, D. (2006) Review of basic medical education in Scotland. BJOG: An International Journal of Obstetrics and Gynaecology, 113(3), pp. 350-356.

2005

Asghar, T., Yoshida, S., Nakago, S., Morizane, M., Ohara, N., Motoyama, S., Kennedy, S., Barlow, D. and Maruo, T. (2005) Lack of association between endornetriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations. Gynecological Endocrinology, 20(2), pp. 59-63.

Bahlo, M. et al. (2005) Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. American Journal of Human Genetics, 77(3), pp. 365-376.

Barlow, D. (2005) The debate on single embryo transfer in IVF. How will today's arguments be viewed from the perspective of 2020? Human Reproduction, 20(1), pp. 1-3.

Barlow, D. (2005) Menopause and HRT - the state of the art in Europe. Maturitas, 51, pp. 40-47. (doi: 10.1016/j.maturitas.2005.02.013)

Barlow, D. (2005) Preimplantation genetic screening will play a dominant role in selecting embryos for single embryo transfer - Reply. Human Reproduction, 20(10), p. 2979.

Barlow, D., Carver, J., Chobotova, K., Gullick, W., Karpovich, N., Manek, S. and Mardon, H. (2005) Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells. Journal of Clinical Endocrinology and Metabolism, 90(2), pp. 913-919.

Barlow, D., Heath, J., Hwang, J., Karpovich, N., Klemmt, P., Mardon, H. and McVeigh, J. (2005) The production of interleukin-11 and decidualization are compromised in endometrial stromal cells derived from patients with infertility. Journal of Clinical Endocrinology and Metabolism, 90, pp. 1607-1612. (doi: 10.1210/jc.2004-0868)

Barlow, D. and Kennedy, S. (2005) Endometriosis: New genetic approaches and therapy. Annual Review of Medicine, 56, pp. 345-356.

Barlow, D., Sargent, I. and Yao, Y. (2005) Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. Journal of Immunology, 175(12), pp. 8379-8385.

Hampton, N., Rees, M., Lowe, D., Rauramo, I., Barlow, D. and Guillebaud, J. (2005) Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Human Reproduction, 20(9), pp. 2653-2660.

Johnson, N., Barlow, D., Lethaby, A., Tavender, E., Curr, E. and Garry, R. (2005) Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database of Systematic Reviews(1),

Johnson, N., Barlow, D., Lethaby, A., Tavender, E., Curr, L. and Garry, R. (2005) Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials. British Medical Journal, 330(7506), pp. 1478-1481.

Skouby, S. et al. (2005) Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas, 51(1), pp. 8-14.

2004

Asghar, T., Yoshida, S., Kennedy, S., Negoro, K., Zhuo, W., Hamana, S., Motoyama, S., Nakago, S., Barlow, D. and Maruo, T. (2004) The tumor necrosis factor-alpha promoter-1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Human Reproduction, 19(11), pp. 2509-2514.

Barlow, D. (2004) Announcement: New departures for Human reproduction in 2004. Human Reproduction, 19(9), pp. 1931-1932.

Barlow, D. (2004) A time for consensus and consistency of reporting in clinical studies and the importance of new basic research. Human Reproduction, 19(1), pp. 1-2.

Barlow, D., Beard, H. and Williams, A. (2004) Assisted reproductive technologies in Europe encompass diverse and complex ethical viewpoints - Issues to be considered in reporting research in human reproduction. Uterus and Human Reproduction, 1034, pp. 110-116.

Barlow, D., Hamana, S., Kennedy, S., Maruo, T., Negoro, K., Omori, S. and Yoshida, S. (2004) Polymorphism at codon 72 of the p53 gene is not associated with endornetriosis in a Japanese population. Journal of the Society For Gynecologic Investigation, 11(4), pp. 232-236.

Burger, H. et al. (2004) Practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric, 7(2), pp. 210-216.

Wang, Z., Yoshida, S., Negoro, K., Kennedy, S., Barlow, D. and Maruo, T. (2004) Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertility and Sterility, 81(6), pp. 1650-1656.

2003

Barlow, D.H. (2003) Estrogen and dementia: it's a long way from the rat to the randomized clinical trial. Menopause: The Journal of the North American Menopause Society, 10(5), pp. 387-389.

Barlow, D. (2003) The design, publication and interpretation of research in Subfertility Medicine: uncomfortable issues and challenges to be faced. Human Reproduction, 18(5), pp. 899-901.

Barlow, D. (2003) Time to reflect on the Women's Health Initiative (WHI) study. Human Reproduction, 18(1), pp. 1-3.

Barlow, D., Carver, J., Chobotova, K., Heath, J., Karpovich, N. and Mardon, H. (2003) Expression and function of interleukin-11 and its receptor alpha in the human endometrium. Molecular Human Reproduction, 9, pp. 75-80. (doi: 10.1093/molehr/gag012)

Carver, J., Martin, K., Spyropoulou, I., Barlow, D., Sargent, I. and Mardon, H. (2003) An in-vitro model for stromal invasion during implantation of the human blastocyst. Human Reproduction, 18(2), pp. 283-290.

Yao, Y., Barlow, D. and Sargent, I. (2003) Detection of alternatively spliced transcripts of human leukocyte antigen-G in single human preimplantation blastocysts using nested RT-PCR. Fertility and Sterility, 80, S77-S77.

2002

Barlow, D. (2002) The children of assisted reproduction - the need for an ongoing debate. Human Reproduction, 17(5), pp. 1133-1134.

Barlow, D. (2002) Cloning-derived technologies warrant intensive research. Human Reproduction, 17(8), p. 1931.

Barlow, D., Bernal, A., Engmann, L., Hoveyda, F. and Steele, J. (2002) Ovarian response in three consecutive in vitro fertilization cycles. Fertility and Sterility, 77(4), pp. 706-710.

Barlow, D., Bragg, A., Campbell, M., O'Brien, K., Sturdee, D., Ulrich, L., Vessey, M. and Wells, M. (2002) Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. British Medical Journal, 325(7358), 239-242A.

Barlow, D., Carver, J., Chobotova, K., Gullick, W., Heath, J., Manek, S., Mardon, H., Sargent, I. and Spyropoulou, I. (2002) Heparin-binding epidermal growth factor and its receptor ErbB4 mediate implantation of the human blastocyst. Mechanisms of Development, 119, pp. 137-144.

Barlow, D., Carver, J., Chobotova, K., Gullick, W., Manek, S., Mardon, H., Muchmore, M. and Yoo, H. (2002) The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha. Journal of Clinical Endocrinology and Metabolism, 87(12), pp. 5769-5777.

Barlow, D., Davidson, L., Davis, L., Garceau, L., Henderson, J., Henderson, L., McVeigh, E. and Petrou, S. (2002) Economic implications of assisted reproductive techniques: a systematic review. Human Reproduction, 17(12), pp. 3090-3109.

Barlow, D., Groome, N., Ledger, W., Muttukrishna, S., Sathanandan, M. and Sharma, S. (2002) Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women. Human Reproduction, 17, pp. 2535-2539.

Barlow, D., Hadfield, R., Kennedy, S., Lambert, A., Montgomery, G., O'Connor, D., Treloar, S. and Wicks, J. (2002) The International Endogene Study: a collection of families for genetic research in endometriosis. Fertility and Sterility, 78(4), pp. 679-685.

Klemmt, P., Carver, J., Koninckx, P., Kennedy, S., Barlow, D. and Mardon, H. (2002) The function of extracellular and their receptors in the pathogenesis of endometriosis. Fertility and Sterility, 77(2), S46-S46.

Wicks, J. et al. (2002) International Endogene Study finds strong evidence of susceptibility loci for endometriosis at two genomic regions. American Journal of Human Genetics, 71(4), p. 215.

2001

Asboth, G., Barlow, D., Bellinger, J., Bernal, A., Ledger, W. and Price, S. (2001) Characterization of adenylyl cyclases in cultured human granulosa cells. Reproduction, 121(2), pp. 217-228.

Barlow, D. (2001) Human reproduction - January 2001. Human Reproduction, 16(1), pp. 1-2.

Barlow, D.H., Dawes, M.G., Jenkinson, C.P., Kennedy, S.H., Vessey, M.P., Yudkin, P.L. and Zondervan, K.T. (2001) The community prevalence of chronic pelvic pain in women and associated illness behaviour. British Journal of General Practice, 51(468), pp. 541-547.

Barlow, D. (2001) Cost-effectiveness modelling. Human Reproduction, 16(12), pp. 2479-2480.

Barlow, D. (2001) Developments in the management of menopause and hormone replacement therapy: a presentation given at the symposium to honour the retirement of Professor Martin Vessey. Pharmacoepidemiology and Drug Safety, 10(1), pp. 29-32.

Barlow, D. (2001) Environmental effects on reproductive health: Introduction. Human Reproduction, 16(5), p. 971.

Barlow, D. (2001) Publication ethics and human reproduction. Human Reproduction, 16(8), p. 1541.

Barlow, D., Dawes, M., Jenkinson, C., Kennedy, S., Vessey, M., Yudkin, P. and Zondervan, K. (2001) Chronic pelvic pain in the community - Symptoms, investigations, and diagnoses. American Journal of Obstetrics and Gynecology, 184(6), pp. 1149-1155.

Barlow, D., Hadfield, R., Kennedy, S., Manek, S., Mardon, H. and Weeks, D. (2001) Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Molecular Human Reproduction, 7(11), pp. 1073-1078.

Nakago, S., Hadfield, R., Zondervan, K., Mardon, H., Manek, S., Weeks, D., Barlow, D. and Kennedy, S. (2001) Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Molecular Human Reproduction, 7(11), pp. 1079-1083.

Sturdee, D., Ulrich, L. and Barlow, D. (2001) The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. (vol 107, pg 1392, 2000). British Journal of Obstetrics and Gynaecology, 108(3), p. 336.

Wells, M., Sturdee, D., Barlow, D., Ulrich, L., O'Brien, K., Campbell, M., Vessey, M. and Bragg, A. (2001) The endometrial response to long term treatment with continuous combined oestrogen-progestogen replacement therapy. Journal of Pathology, 195, 2A-2A.

2000

Barlow, D. (2000) Venlafaxine for hot flushes. Lancet, 356(9247), pp. 2025-2026.

This list was generated on Thu Nov 21 02:21:25 2024 GMT.

Jump to: Articles